Keyphrases
Obesity
98%
Cluster of Differentiation 44 (CD44)
86%
Extracellular Matrix
72%
Matrix Expansion
57%
Myocardial Insulin Resistance
57%
Myocardial Remodeling
57%
Diet-induced Obese Mice
57%
Cell Surface Receptor
57%
Metabolic Disorders
57%
Extracellular Matrix Remodeling
57%
O-linked N-acetylglucosamine (O-GlcNAc)
57%
Diabetic Nephropathy
57%
O-GlcNAc Modification
57%
Therapeutic Target
57%
Adipogenesis
57%
Related Pathway
57%
Hyaluronan
47%
Extracellular Matrix Protein 1 (ECM1)
45%
Insulin Resistance
41%
Extracellular Matrix Deposition
39%
Collagen
39%
Protein O-GlcNAcylation
38%
Obese Mice
33%
Adhesome
28%
Fibrosis
28%
Integrin Receptor
28%
O-GlcNAcylation
28%
Obesity Treatment
22%
Insulin Sensitivity
22%
Therapeutic Potential
21%
Renal Interstitial Fibrosis
19%
Kidney Cells
19%
Cell Surface
18%
High-fat Diet
16%
PEGPH20
16%
Pirfenidone
16%
Cardiac Tissue
16%
Re-expression
15%
Causes of Obesity
14%
Cardiometabolic Complications
14%
Tissue Metabolism
14%
Metabolic Dysfunction
14%
Cell Signaling
14%
Matrix Cell
14%
Undernutrition
14%
Glycoprotein
14%
Growth Factors
14%
Complex Networks
14%
Cytokine Factors
14%
Signaling Molecules
14%
Catalytic Activity
14%
Molecular Mechanism
14%
Specific Interactions
14%
Ligand-specific
14%
Extracellular Environment
14%
Specific Action
14%
Matrix Polysaccharides
14%
Cell number
14%
Serious Pathology
14%
Pathophysiological Mechanisms
14%
Signaling Cascades
14%
Adhesion Proteins
14%
Parvin
14%
Cell Adhesion Proteins
14%
Matrix Protein
14%
Receptor-mediated
14%
Metabolic Effects
14%
Receptor-ligand Interaction
14%
Preadipocytes
11%
Adipocyte
11%
Current Treatment
9%
Disease Progression
9%
Renal Cell
9%
Hexosamine Pathway
9%
Hyperglycemia
9%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
9%
Renal Tubular Epithelial Cells
9%
UDP-GlcNAc
9%
Kidney Injury
9%
Renin-angiotensin-aldosterone System Inhibitors
9%
Narrative Review
9%
Podocyte
9%
Glucose Flux
9%
Cell Damage
9%
Protein Post-translational Modification
9%
Aminotransferase
9%
Mesangial Cells
9%
Fructose
9%
Obesity Prevention
8%
Disease Clusters
8%
Functional Change
8%
Genomic Deletion
8%
Cardiac Dysfunction
8%
Resistance Diseases
8%
Pharmacological Approaches
8%
Cardiac Function
8%
Matrix metalloproteinase-9 (MMP-9)
8%
Recombinant Hyaluronidase
8%
Cardiac Extracellular Matrix
8%
Tight
8%
Novel Therapeutics
8%
In Vivo Analysis
8%
Diet-induced
8%
Hyperinsulinemic-euglycemic Clamp
8%
Genetic Approach
8%
Heart Disease
8%
Collagen Expression
8%
Insulin Action
8%
PEGylated
8%
Pressure-volume Loop Analysis
8%
Mouse Model
8%
C57BL
8%
Collagen Deposition
8%
Antifibrotic
8%
Cardiovascular Complications
8%
Biochemistry, Genetics and Molecular Biology
Insulin Resistance
100%
CD44
96%
Metabolic Disorder
57%
Cell Cycle
57%
Mouse Mutant
57%
Adipogenesis
57%
Cell Surface Receptor
57%
Peroxisome Proliferator-Activated Receptor
57%
Restylane
48%
Integrin
38%
Growth Factor
19%
Polysaccharide
19%
Signal Transduction
19%
Cytokine
19%
Cell Adhesion Proteins
19%
Tissue Metabolism
19%
Glycoprotein
19%
Enzymatic Activity
19%
Adhesion Protein
19%
Matrix Protein
19%
Preadipocyte
14%
Adipocyte
14%
Gene Deletion
10%
Mouse Model
7%
Heart Function
7%
Hyaluronidase
7%
Recombinant
7%
Disease Classification
7%
Gelatinase B
7%
MMP9
7%
Insulin Sensitivity
7%
C57BL 6 Mouse
7%
Genetics
7%
Medicine and Dentistry
N Acetylglucosamine
57%
Extracellular Matrix
57%
Insulin Resistance
57%
Diet Induced Obesity
57%
Diabetic Nephropathy
57%
Restylane
28%
Idiopathic Pulmonary Fibrosis
19%
Kidney Cell
19%
Pirfenidone
14%
High Fat Food
14%
Disease Exacerbation
9%
Podocyte
9%
Uridine Diphosphate
9%
Renin Angiotensin Aldosterone System
9%
Kidney Injury
9%
Hyperglycemia
9%
Fructose
9%
Hexosamine
9%
Cell Damage
9%
Protein Processing
9%
Mesangial Cell
9%
Transaminase
9%
Sodium Glucose Cotransporter 2 Inhibitor
9%
Heart Function
7%
C57BL/6
7%
Insulin Sensitivity
7%
Nosology
7%
Gelatinase B
7%
Heart Disease
7%
Recombinant Hyaluronidase
7%
Drug Therapy
7%
Gene Deletion
7%
Cardiovascular Disease
7%